|
Are stocking
levels of your new product meeting forecasted goals?
At what rate
are new competitors or generic substitutes displacing your established
product on retail shelves?
Pharmacy stocking trends and
practices affect product sales both directly and indirectly.
Short stocking can lead to substitution, costing you long-term
sales as well as immediate losses. Whether you're looking at
a new, established, or generic product, DMD keeps you in touch
with activity in the retail pharmacy segment.
The Retail PIP has proven
valuable to:
| |
Track
new product introductions - measuring actual
stocking levels against forecasting goals |
| |
Identify
changes in stocking, inventory, and use and to quantify
cannibalization of established products |
| |
Benchmark
established products for a new product launch |
| |
Quantify
erosion rates of new competitors or generics on your brand |
| |
Monitor
the impact of stocking or deal programs |
| |
Check
the price to consumers or the pharmacy's acquisition cost |
| |
Answer
proprietary questions about pharmacy related issues |
| |
Pinpoint
stocking within exclusive sales regions |
Sample and Methodology
DMD conducts a monthly mail survey
of 400 retailers selected from our panel of 5,000. The PIP sample
is representative by region and store ownership - large chain
stores (100 or more pharmacies) and small chains/independents
(fewer that 100 pharmacies).
Pharmacists report their current
inventory (including estimates on partial bottles), and the estimated
number of bottles sold in the last 30 days. If desired, DMD can
also obtain acquisition cost, price to the patient and product
on order status.
Custom Studies Available
DMD can perform the Retail Pharmacy
Inventory Plus study as a custom project if different sample
composition or timing is required. See Explore
for more information.
|